Toggle Main Menu Toggle Search

Open Access padlockePrints

Metabolic effects of bezafibrate in mitochondrial disease.

Lookup NU author(s): Dr Hannah Steele, Dr Angela Pyle, Sila Hopton, Jane Newman, Dr Renae StefanettiORCiD, Dr Sarah CharmanORCiD, Dr Jehill Parikh, Dr Langping He, Professor Djordje JakovljevicORCiD, Dr Kieren Hollingsworth, Professor Robert Taylor, Professor Rita HorvathORCiD, Professor Patrick Chinnery

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Publication metadata

Author(s): Steele H, Gomez-Duran A, Pyle A, Hopton S, Newman J, Stefanetti RJ, Charman SJ, Parikh JD, He L, Viscomi C, Jakovljevic DG, Hollingsworth KG, Robinson AJ, Taylor RW, Bottolo L, Horvath R, Chinnery PF

Publication type: Article

Publication status: Published

Journal: EMBO Molecular Medicine

Year: 2020

Volume: 12

Issue: 3

Online publication date: 28/02/2020

Acceptance date: 29/01/2020

Date deposited: 04/03/2020

ISSN (electronic): 1757-4684

Publisher: EMBO Press

URL: https://doi.org/10.15252/emmm.201911589

DOI: 10.15252/emmm.201911589

PubMed id: 32107855


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
201064/Z/16/ZWellcome Trust
203105/Z/16/ZWellcome Trust
212219/Z/18/Z
109915/Z/15/ZWellcome Trust
13/NE/0326
309548
EP/N510129/1
G0800674
MC_UU_00015/9
MR/N025431/1Medical Research Council (MRC)
MR/N027302/1Medical Research Council (MRC)
MRC/ESPRC Molecular Pathology Node
The Lily Foundation
UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children
UK National Institute for Health Research Biomedical Research Centre in Age and Age-Related Diseases

Share